Company / Tangible Book Value per Share
Xeris Biopharma Holdings, Inc. Tangible Book Value per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
-$0.06
FY2025
5-year range
-$0.38 / $1.70
FY2021-FY2025
Trend
+83.8%
vs FY2024
Sector context
#184 of 209
Health Care
What the data says
Xeris Biopharma Holdings, Inc.'s tangible book value per share of $-0.06 is lower than 88% of companies in the Health Care sector (FY2025). Tangible Book Value per Share returned to growth in FY2025 after 3 years of decline, reaching $-0.06.
Based on SEC 10-K filings.
-0.06 in FY2025.
Improved from $-0.22 to $-0.06 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 209This company -$0.06 Sector average $93.47
▼
-100.1% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 83.8% year-over-year.
- Ranks #184 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.26 (distress zone, below 1.8 threshold)
- Negative profit margin: -27.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.06 | +83.8% |
| FY2024 | -$0.38 | -74.7% |
| FY2023 | -$0.22 | -349.1% |
| FY2022 | $0.09 | -94.9% |
| FY2021 | $1.70 | +114.4% |
| FY2020 | $0.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026